Porcine Vaccine Industry Anticipated to Expand at 9.4% CAGR During the Forecast Period

November 12, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Porcine Vaccine Market By 2029?

The porcine vaccine market has shown robust growth in recent years. This market is forecasted to expand from $1.89 billion in 2024 to $2.05 billion in 2025, progressing at a compound annual growth rate (CAGR) of 8.5%. Historically, this expansion has been propelled by elements such as disease outbreaks and implemented control measures, a global rise in pork consumption, the intensification of pig farming, government initiatives for disease control, and awareness and education programs.

The porcine vaccine market is projected to experience substantial expansion in the coming years, anticipated to reach $2.94 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.4%. This projected growth during the forecast period is attributable to factors such as the worldwide growth of pig farming, increasing disease threats, strict regulations and adherence requirements, innovations in vaccine technology, and global efforts in trade and disease risk reduction. Key trends anticipated within this period encompass tailoring vaccines to address specific regional issues, incorporating biotechnology into vaccine creation, heightened worries regarding zoonotic illnesses, utilizing genomic methods in vaccine formulation, and increasing financial commitments to research and development.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp

Which Drivers Are Supporting Growth Of The Porcine Vaccine Market?

The growing prevalence of swine diseases is projected to drive the expansion of the porcine vaccine market in the future. Swine influenza, often referred to as swine flu, is a respiratory ailment in pigs primarily triggered by the type A influenza virus, leading to common outbreaks among them. Porcine vaccines are administered to pigs, prompting their immune systems to respond and recognize the pathogenic agent by eliciting an immunogenic reaction. Such vaccines prime the swine’s immune system to combat pathogens and avert illness through an anamnestic reaction upon subsequent exposure to the same pathogen. For example, reports from the Government of the United Kingdom, an information website, indicated in September 2024 that an African swine fever (ASF) outbreak could significantly impact the UK’s pig industry, valued at £8 billion, and its £600 million yearly exports of pork and related products. The financial repercussions of such an event are estimated to be between £10 million and £100 million. Consequently, the increasing incidence of swine diseases is stimulating demand in the porcine vaccine market.

What Are The Emerging Segments Gaining Attention In The Porcine Vaccine Market?

The porcine vaccine market covered in this report is segmented –

1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines

2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications

3) By End User: Veterinary Hospitals, Hog or Pig Production Farm

Subsegments:

1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines, Subunit Inactivated Vaccines

2) By Live Attenuated Vaccines: Live Modified Vaccines, Live Virulent Vaccines

3) By Toxoid Vaccines: Inactivated Toxins

4) By Recombinant Vaccines: Recombinant Vector Vaccines, Subunit Recombinant Vaccines

5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines

6) By DNA Vaccines: Plasmid DNA Vaccines

Which Trends Are Impacting The Porcine Vaccine Market?

Leading entities within the porcine vaccine market are embracing strategic collaborations to bolster their research and development capacities and reinforce their competitive standing in the dynamic animal health sector. This collaborative effort leverages TVG’s proficiency in vaccine technology and Pirbright’s specialized knowledge in African swine fever (ASF) investigations. The primary objective of this alliance is to optimize the vaccine development procedure and conceive innovative strategies that could significantly advance swine health. An example of this is the partnership formed in May 2024, where The Pirbright Institute, a UK-based research institute, joined forces with The Vaccine Group (TVG), a UK-based company, with the aim of creating a vaccine for African swine fever (ASF). This research endeavors to produce vaccines capable of preventing African swine fever (ASF), utilizing bovine herpesvirus 4 (BoHV-4) as its underlying platform. Such an approach capitalizes on recent advancements in ASF vaccine studies and pig immunology to engineer more effective vaccines. Funding for this initiative is provided by the U.K.’s Department for Environment, Food and Rural Affairs (Defra) and the Biotechnology and Biological Sciences Research Council (BBSRC).

Who Are The Core Companies Influencing The Porcine Vaccine Market Landscape?

Major companies operating in the porcine vaccine market include Sanofi Pasteur Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Arko Laboratories Limited, Merck Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale, Huvepharma Inc., Phibro Animal Health Corporation, Vetoquinol SA, Intervet Inc., HIPRA S.A., Ringpu Bio-Pharmacy Co Ltd., IDT Biologika GmbH, Bimeda Holdings PLC, Jinyu Bio-Technology Co Ltd., Biogénesis Bagó, Pharmaq AS, Veterquimica S.A., Kyoto Biken Laboratories Inc., Dopharma Research B.V., Agrovet Market Animal Health Ltd., Innovad SA, PBS Animal Health, Merial Animal Health, Aptimmune Biologics Inc., Syntex SA de CV, Zoovet S.A., Shenzhen Weierkang Xiang Animal Pharm Co Ltd., Wuhan Keqian Biology Co Ltd., Anicon Labor GmbH

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report

What Are The Regional Market Dynamics Impacting The Porcine Vaccine Industry?

North America is the largest region in the porcine vaccine market in 2024. The regions covered in the porcine vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Porcine Vaccine Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9111&type=smp

Browse Through More Reports Similar to the Global Porcine Vaccine Market 2025, By The Business Research Company

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795